Integrum
its OPRA implant system, an osseointegration technology that anchors a prosthesis directly to bone, demonstrated superior treatment outcomes in a two-year follow-up study by Walter Reed National Military Medical Center, and the company is expanding implant system access in Ukraine.
- Country
- Sweden
- Ticker
- INTEG B
Osseointegration
Nasdaq Stockholm: INTEG B
eu
Coverage
| CN | EU | US | |
|---|---|---|---|
| regenerative-personalized | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bionic prostheses & neuroprosthetics | regenerative-personalized | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.